Insulin detemir in the treatment of type 1 and type 2 diabetes.
about
An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.Insulin detemir for the treatment of obese patients with type 2 diabetes.Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism.Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.[Insulin degludec--a new basal insulin for the treatment of type 1 and type 2 diabetes].
P2860
Insulin detemir in the treatment of type 1 and type 2 diabetes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Insulin detemir in the treatment of type 1 and type 2 diabetes.
@ast
Insulin detemir in the treatment of type 1 and type 2 diabetes.
@en
type
label
Insulin detemir in the treatment of type 1 and type 2 diabetes.
@ast
Insulin detemir in the treatment of type 1 and type 2 diabetes.
@en
prefLabel
Insulin detemir in the treatment of type 1 and type 2 diabetes.
@ast
Insulin detemir in the treatment of type 1 and type 2 diabetes.
@en
P2860
P921
P1476
Insulin detemir in the treatment of type 1 and type 2 diabetes.
@en
P2093
André Scheen
Jean-Christophe Philips
P2860
P304
P356
10.2147/VHRM.2006.2.3.277
P407
P577
2006-01-01T00:00:00Z